NEW YORK, Sept. 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Arterial Thrombosis Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02353407/Arterial-Thrombosis-Global-Clinical-Trials-Review-H2-2014.html
Arterial Thrombosis Global Clinical Trials Review, H2, 2014
Summary
GlobalData's clinical trial report, "Arterial Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Arterial Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arterial Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Arterial Thrombosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
Introduction 6Arterial Thrombosis 6Report Guidance 6Clinical Trials by Region 7Clinical Trials and Average Enrollment by Country 8Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10Top Five Countries Contributing to Clinical Trials in Europe 11Top Countries Contributing to Clinical Trials in North America 12Top Countries Contributing to Clinical Trials in Middle East and Africa 13Top Five Countries Contributing to Clinical Trials in Central and South America 14Clinical Trials by G7 Countries: Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials 15Clinical Trials by Phase in G7 Countries 16Clinical Trials in G7 Countries by Trial Status 17Clinical Trials by E7 Countries: Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials 18Clinical Trials by Phase in E7 Countries 19Clinical Trials in E7 Countries by Trial Status 20Clinical Trials by Phase 21In Progress Trials by Phase 22Clinical Trials by Trial Status 23Clinical Trials by End Point Status 24Subjects Recruited Over a Period of Time 25Clinical Trials by Sponsor Type 26Prominent Sponsors 27Top Companies Participating in Arterial Thrombosis Therapeutics Clinical Trials 28Prominent Drugs 29Clinical Trial Profiles 30Clinical Trial Overview of Top Companies 30AstraZeneca PLC 30Clinical Trial Overview of AstraZeneca PLC 30Arena Pharmaceuticals, Inc. 31Clinical Trial Overview of Arena Pharmaceuticals, Inc. 31Takeda Pharmaceutical Company Limited 32Clinical Trial Overview of Takeda Pharmaceutical Company Limited 32Hanwha Chemical Co., Ltd. 33Clinical Trial Overview of Hanwha Chemical Co., Ltd. 33Ildong Pharmaceutical Co., Ltd. 34Clinical Trial Overview of Ildong Pharmaceutical Co., Ltd. 34Bristol-Myers Squibb Company 35Clinical Trial Overview of Bristol-Myers Squibb Company 35Clinical Trial Overview of Top Institutes / Government 36Tufts Medical Center 36Clinical Trial Overview of Tufts Medical Center 36The Newcastle upon Tyne Hospitals NHS Foundation Trust 37Clinical Trial Overview of The Newcastle upon Tyne Hospitals NHS Foundation Trust 37Sheffield Teaching Hospitals NHS Foundation Trust 38Clinical Trial Overview of Sheffield Teaching Hospitals NHS Foundation Trust 38Meir Medical Center 39Clinical Trial Overview of Meir Medical Center 39St. Antonius Hospital 40Clinical Trial Overview of St. Antonius Hospital 40British Heart Foundation 41Clinical Trial Overview of British Heart Foundation 41All India Institute of Medical Sciences 42Clinical Trial Overview of All India Institute of Medical Sciences 42University of Oxford 43Clinical Trial Overview of University of Oxford 43Hopitaux Universitaires de Geneve 44Clinical Trial Overview of Hopitaux Universitaires de Geneve 44Five Key Clinical Profiles 45Appendix 63Abbreviations 63Definitions 63Research Methodology 64Secondary Research 64About GlobalData 65Contact Us 65Disclaimer 65Source 65
List of Tables
Arterial Thrombosis Therapeutics, Global, Clinical Trials by Region, 2014* 7Arterial Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8Arterial Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9Arterial Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10Arterial Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11Arterial Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12Arterial Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13Arterial Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15Arterial Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16Arterial Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18Arterial Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19Arterial Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20Arterial Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21Arterial Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22Arterial Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23Arterial Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24Arterial Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25Arterial Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26Arterial Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27Arterial Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28Arterial Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 30Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arena Pharmaceuticals, Inc., 2014* 31Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 32Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hanwha Chemical Co., Ltd., 2014* 33Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ildong Pharmaceutical Co., Ltd., 2014* 34Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 35Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts Medical Center, 2014* 36Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Newcastle upon Tyne Hospitals NHS Foundation Trust, 2014* 37Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheffield Teaching Hospitals NHS Foundation Trust, 2014* 38Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Meir Medical Center, 2014* 39Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Antonius Hospital, 2014* 40Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by British Heart Foundation, 2014* 41Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014* 42Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 43Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2014* 44
List of Figures
Arterial Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7Arterial Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8Arterial Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9Arterial Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10Arterial Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11Arterial Thrombosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12Arterial Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13Arterial Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15Arterial Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16Arterial Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18Arterial Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19Arterial Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20Arterial Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21Arterial Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22Arterial Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23Arterial Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24Arterial Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25Arterial Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26Arterial Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27Arterial Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28Arterial Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29GlobalData Methodology 64
To order this report: Arterial Thrombosis Global Clinical Trials Review, H2, 2014 http://www.reportlinker.com/p02353407/Arterial-Thrombosis-Global-Clinical-Trials-Review-H2-2014.html
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article